{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:50:23Z","timestamp":1769129423036,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T00:00:00Z","timestamp":1461628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences (US)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11046-016-0010-y","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T00:27:37Z","timestamp":1461630457000},"page":"561-566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lichtheimia Infection in a Lymphoma Patient: Case Report and a Brief Review of the Available Diagnostic Tools"],"prefix":"10.1007","volume":"181","author":[{"given":"Stefan","family":"Zimmerli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Bialek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor W.","family":"Blau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Christe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Presterl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,26]]},"reference":[{"issue":"1","key":"10_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408410903241444","volume":"36","author":"MA Pfaller","year":"2010","unstructured":"Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol. 2010;36(1):1\u201353. doi: 10.3109\/10408410903241444 .","journal-title":"Crit Rev Microbiol"},{"issue":"7","key":"10_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3201\/eid2007.140087","volume":"20","author":"D Bitar","year":"2014","unstructured":"Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, et al. Population-based analysis of invasive fungal infections, France, 2001\u20132010. Emerg Infect Dis. 2014;20(7):1163\u20139. doi: 10.3201\/eid2007.140087 .","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10_CR3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell Transplantant recipients, 2001\u20132006: overview of the Transplantant-associated infection surveillance network (TRANSNET) database. Clin Infect Dis. 2010;50(8):1091\u2013100. doi: 10.1086\/651263 .","journal-title":"Clin Infect Dis"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/CLEP.S12502","volume":"3","author":"J Kriengkauykiat","year":"2011","unstructured":"Kriengkauykiat J, Ito JI, Dadwal SS. Epidemiology and treatment approaches in management of invasive fungal infections. Clin Epidemiol. 2011;3:175\u201391. doi: 10.2147\/CLEP.S12502 .","journal-title":"Clin Epidemiol."},{"key":"10_CR5","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2011.012","author":"G Petrikkos","year":"2011","unstructured":"Petrikkos G, Drogari-Apiranthitou M. Zygomycosis in immunocompromised non-haematological patients. Mediterr J Hematol Infect Dis. 2011. doi: 10.4084\/mjhid.2011.012 .","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"8","key":"10_CR6","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1086\/597396","volume":"48","author":"BE Pauw De","year":"2009","unstructured":"De Pauw BE, Donnelly JP. Timely intervention for invasive fungal disease: should the road now lead to the laboratory instead of the pharmacy? Clin Infect Dis. 2009;48(8):1052\u20134. doi: 10.1086\/597396 .","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10_CR7","first-page":"986","volume":"91","author":"G Chamilos","year":"2006","unstructured":"Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica. 2006;91(7):986\u20139.","journal-title":"Haematologica"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/myc.12081","volume":"56","author":"RE Lewis","year":"2013","unstructured":"Lewis RE, Cahyame-Zuniga L, Leventakos K, Chamilos G, Ben-Ami R, Tamboli P, et al. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses. 2013;56:638\u201345. doi: 10.1111\/myc.12081 .","journal-title":"Mycoses"},{"issue":"Suppl 1","key":"10_CR9","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.3109\/13693786.2010.505204","volume":"49","author":"JW Baddley","year":"2011","unstructured":"Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol. 2011;49(Suppl 1):S7\u201312. doi: 10.3109\/13693786.2010.505204 .","journal-title":"Med Mycol"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1749-6632.2012.06829.x","volume":"1272","author":"R Herbrecht","year":"2012","unstructured":"Herbrecht R, Bories P, Moulin JC, Ledoux MP, Letscher-Bru V. Risk stratification for invasive aspergillosis in immunocompromised patients. Ann NY Acad Sci. 2012;1272:23\u201330. doi: 10.1111\/j.1749-6632.2012.06829.x .","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"10_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","volume":"177","author":"W Meersseman","year":"2008","unstructured":"Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med. 2008;177(1):27\u201334. doi: 10.1164\/rccm.200704-606OC .","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10_CR12","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/bmt.2011.178","volume":"47","author":"O Marchetti","year":"2012","unstructured":"Marchetti O, Lamoth F, Mikulska M, Viscoli C, Verweij P, Bretagne S, et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant. 2012;47(6):846\u201354. doi: 10.1038\/bmt.2011.178 .","journal-title":"Bone Marrow Transplant"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/annonc\/mdu192","volume":"26","author":"G Maschmeyer","year":"2015","unstructured":"Maschmeyer G, Carratala J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C, et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2015;26:21\u201333. doi: 10.1093\/annonc\/mdu192 .","journal-title":"Ann Oncol"},{"issue":"4","key":"10_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/annonc\/mdr407","volume":"23","author":"M Ruhnke","year":"2012","unstructured":"Ruhnke M, B\u00f6hme A, Buchheidt D, Cornely O, Donhuijsen K, Einsele H, et al. Diagnosis of invasive fungal infections in hematology and oncology\u2014guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO). Ann Oncol. 2012;23(4):823\u201333. doi: 10.1093\/annonc\/mdr407 .","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"10_CR15","doi-asserted-by":"publisher","first-page":"i37","DOI":"10.1093\/jac\/dkq440","volume":"66","author":"J Maertens","year":"2011","unstructured":"Maertens J, Groll AH, Cordonnier C, de la Camara R, Roilides E, Marchetti O. Treatment and timing in invasive mould disease. J Antimicrob Chemother. 2011;66(Suppl 1):i37\u201343. doi: 10.1093\/jac\/dkq440 .","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10_CR16","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1086\/496927","volume":"41","author":"J Maertens","year":"2005","unstructured":"Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E, et al. Galactomannan and computed tomography\u2013based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis. 2005;41(9):1242\u201350. doi: 10.1086\/496927 .","journal-title":"Clin Infect Dis"},{"issue":"Suppl 6","key":"10_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/1469-0691.12617","volume":"20","author":"A Alanio","year":"2014","unstructured":"Alanio A, Bretagne S. Difficulties with molecular diagnostic tests for mould and yeast infections: where do we stand? Clin Microbiol Infect. 2014;20(Suppl 6):36\u201341. doi: 10.1111\/1469-0691.12617 .","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10_CR18","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1128\/JCM.39.4.1506-1509.2001","volume":"39","author":"R Bialek","year":"2001","unstructured":"Bialek R, Fischer J, Feucht A, Najvar LK, Dietz K, Knobloch J, et al. Diagnosis and monitoring of murine histoplasmosis by a nested PCR assay. J Clin Microbiol. 2001;39(4):1506\u20139. doi: 10.1128\/JCM.39.4.1506-1509.2001 .","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10_CR19","doi-asserted-by":"publisher","first-page":"E271","DOI":"10.1111\/1469-0691.12110","volume":"19","author":"MJ Buitrago","year":"2013","unstructured":"Buitrago MJ, Aguado JM, Ballen A, Bernal-Martinez L, Prieto M, Garcia-Reyne A, et al. Efficacy of DNA amplification in tissue biopsy samples to improve the detection of invasive fungal disease. Clin Microbiol Infect. 2013;19(6):E271\u20137. doi: 10.1111\/1469-0691.12110 .","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10096-005-0078-7","volume":"25","author":"V Rickerts","year":"2006","unstructured":"Rickerts V, Just-Nubling G, Konrad F, Kern J, Lambrecht E, Bohme A, et al. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur J Clin Microbiol Infect Dis. 2006;25(1):8\u201313. doi: 10.1007\/s10096-005-0078-7 .","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"10_CR21","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","volume":"15","author":"AH Groll","year":"2014","unstructured":"Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell Transplantantation. Lancet Oncol. 2014;15(8):e327\u201340. doi: 10.1016\/S1470-2045(14)70017-8","journal-title":"Lancet Oncol"},{"issue":"5","key":"10_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/bmt.2010.175","volume":"46","author":"J Maertens","year":"2011","unstructured":"Maertens J, Marchetti O, Herbrecht R, Cornely OA, Fluckiger U, Frere P, et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell Transplantant recipients: summary of the ECIL 3\u20132009 update. Bone Marrow Transplant. 2011;46(5):709\u201318. doi: 10.1038\/bmt.2010.175 .","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10_CR23","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2012.03976.x","volume":"19","author":"L Bernal-Martinez","year":"2013","unstructured":"Bernal-Martinez L, Buitrago MJ, Castelli MV, Rodriguez-Tudela JL, Cuenca-Estrella M. Development of a single tube multiplex real-time PCR to detect the most clinically relevant Mucormycetes species. Clin Microbiol Infect. 2013;19(1):E1\u20137. doi: 10.1111\/j.1469-0691.2012.03976.x .","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10_CR24","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/cid\/cir122","volume":"52","author":"SP Georgiadou","year":"2011","unstructured":"Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DP. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis. 2011;52(9):1144\u201355. doi: 10.1093\/cid\/cir122 .","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10_CR25","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813\u201321. doi: 10.1086\/588660 .","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10_CR26","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2165\/00003495-200868140-00002","volume":"68","author":"MJ R\u00fcping","year":"2008","unstructured":"R\u00fcping MJ, Vehreschild JJ, Cornely OA. Patients at high risk of invasive fungal infections: when and how to treat. Drugs. 2008;68(14):1941\u201362.","journal-title":"Drugs"},{"issue":"9","key":"10_CR27","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1093\/jac\/dks189","volume":"67","author":"J Auberger","year":"2012","unstructured":"Auberger J, Lass-Florl C, Aigner M, Clausen J, Gastl G, Nachbaur D. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. J Antimicrob Chemother. 2012;67(9):2268\u201373. doi: 10.1093\/jac\/dks189 .","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"10_CR28","doi-asserted-by":"publisher","first-page":"i55","DOI":"10.1093\/jac\/dkq442","volume":"66","author":"BE Pauw De","year":"2011","unstructured":"De Pauw BE, Viscoli C. Managing invasive fungal infections: relying on clinical instincts or on a rational navigation system? J Antimicrob Chemother. 2011;66(Suppl 1):i55\u20138. doi: 10.1093\/jac\/dkq442 .","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00277-013-1854-6","volume":"93","author":"H Bertz","year":"2014","unstructured":"Bertz H, Drognitz K, Lubbert M. No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year \u201creal-life\u201d evaluation. Ann Hematol. 2014;93(1):165\u20137. doi: 10.1007\/s00277-013-1854-6 .","journal-title":"Ann Hematol"},{"key":"10_CR30","doi-asserted-by":"publisher","unstructured":"Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Raffoux E et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood. 2012;119(8):1831\u20137; quiz 956. doi: 10.1182\/blood-2011-04-351601 .","DOI":"10.1182\/blood-2011-04-351601"},{"issue":"3","key":"10_CR31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1148\/radiology.157.3.3864189","volume":"157","author":"JE Kuhlman","year":"1985","unstructured":"Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology. 1985;157(3):611\u20134. doi: 10.1148\/radiology.157.3.3864189 .","journal-title":"Radiology"},{"issue":"5","key":"10_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/cid\/cit929","volume":"58","author":"C Legouge","year":"2014","unstructured":"Legouge C, Caillot D, Chretien ML, Lafon I, Ferrant E, Audia S, et al. The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia? Clin Infect Dis. 2014;58(5):672\u20138. doi: 10.1093\/cid\/cit929 .","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 3","key":"10_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1469-0691.12371","volume":"20","author":"OA Cornely","year":"2014","unstructured":"Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014;20(Suppl. 3):5\u201326. doi: 10.1111\/1469-0691.12371 .","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10_CR34","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.bbmt.2010.11.013","volume":"17","author":"MH Nguyen","year":"2011","unstructured":"Nguyen MH, Leather H, Clancy CJ, Cline C, Jantz MA, Kulkarni V, et al. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell Transplantant recipients. Biol Blood Marrow Transplant. 2011;17(7):1043\u201350. doi: 10.1016\/j.bbmt.2010.11.013 .","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10_CR35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1309\/AJCP99OOOZSNISCZ","volume":"131","author":"AR Sangoi","year":"2009","unstructured":"Sangoi AR, Rogers WM, Longacre TA, Montoya JG, Baron EJ, Banaei N. Challenges and pitfalls of morphologic identification of fungal infections in histologic and cytologic specimens: a ten-year retrospective review at a single institution. Am J Clin Pathol. 2009;131(3):364\u201375. doi: 10.1309\/AJCP99OOOZSNISCZ .","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10_CR36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.diagmicrobio.2014.03.020","volume":"79","author":"SC Heng","year":"2014","unstructured":"Heng SC, Chen SC, Morrissey CO, Thursky K, Manser RL, De Silva HD, et al. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies. Diagn Microbiol Infect Dis. 2014;79(3):322\u20137. doi: 10.1016\/j.diagmicrobio.2014.03.020 .","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/bjh.13114","volume":"168","author":"MM Ceesay","year":"2015","unstructured":"Ceesay MM, Desai SR, Berry L, Cleverley J, Kibbler CC, Pomplun S, et al. A comprehensive diagnostic approach using galactomannan, targeted beta-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients. Br J Haematol. 2015;168(2):219\u201329. doi: 10.1111\/bjh.13114 .","journal-title":"Br J Haematol"},{"issue":"11","key":"10_CR38","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1086\/647942","volume":"49","author":"S Koo","year":"2009","unstructured":"Koo S, Bryar JM, Page JH, Baden LR, Marty FM. Diagnostic performance of the (1\u2013>3) Beta-d-Glucan assay for invasive fungal disease. Clin Infect Dis. 2009;49(11):1650\u20139. doi: 10.1086\/647942 .","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10_CR39","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1128\/jcm.00256-11","volume":"49","author":"SP Hammond","year":"2011","unstructured":"Hammond SP, Bialek R, Milner DA, Petschnigg EM, Baden LR, Marty FM. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol. 2011;49(6):2151\u20133. doi: 10.1128\/jcm.00256-11 .","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10_CR40","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1128\/JCM.00905-15","volume":"53","author":"PL White","year":"2015","unstructured":"White PL, Barnes RA, Springer J, Klingspor L, Cuenca-Estrella M, Morton CO, et al. Clinical performance of aspergillus PCR for testing serum and plasma: a study by the European aspergillus PCR initiative. J Clin Microbiol. 2015;53(9):2832\u20137. doi: 10.1128\/JCM.00905-15 .","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10_CR41","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1086\/521245","volume":"45","author":"C Lass-Fl\u00f6rl","year":"2007","unstructured":"Lass-Fl\u00f6rl C, Resch G, Nachbaur D, Mayr A, Gastl G, Auberger J, et al. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis. 2007;45(7):e101\u20134. doi: 10.1086\/521245 .","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10_CR42","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1086\/512812","volume":"44","author":"V Rickerts","year":"2007","unstructured":"Rickerts V, Mousset S, Lambrecht E, Tintelnot K, Schwerdtfeger R, Presterl E, et al. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin Infect Dis. 2007;44(8):1078\u201383. doi: 10.1086\/512812 .","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10_CR43","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/pbc.25091","volume":"61","author":"G Kropshofer","year":"2014","unstructured":"Kropshofer G, Kneer A, Edlinger M, Meister B, Salvador C, Lass-Florl C, et al. Computed tomography guided percutaneous lung biopsies and suspected fungal infections in pediatric cancer patients. Pediatr Blood Cancer. 2014;61(9):1620\u20134. doi: 10.1002\/pbc.25091 .","journal-title":"Pediatr Blood Cancer"},{"key":"10_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.mmcr.2013.08.002","volume":"2","author":"G Kropshofer","year":"2013","unstructured":"Kropshofer G, Meister B, Lass-Florl C, Crazzolara R. Why is biopsy of suspected fungal lung lesions necessary? Med Mycol Case Rep. 2013;2:141\u20133. doi: 10.1016\/j.mmcr.2013.08.002 .","journal-title":"Med Mycol Case Rep"},{"issue":"5","key":"10_CR45","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1086\/527567","volume":"46","author":"C Lass-Fl\u00f6rl","year":"2008","unstructured":"Lass-Fl\u00f6rl C, Freund MC, Nachbaur D. Rate of complications in immunocompromised patients and unexpectedly high proportion of zygomycetes in computed tomography-guided percutaneous lung biopsy specimens. Clin Infect Dis. 2008;46(5):784\u20135.","journal-title":"Clin Infect Dis"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-016-0010-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-016-0010-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-016-0010-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T23:45:59Z","timestamp":1559346359000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-016-0010-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,26]]},"references-count":45,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10"],"URL":"https:\/\/doi.org\/10.1007\/s11046-016-0010-y","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,26]]}}}